"Designing Growth Strategies is in our DNA"

Urinary Retention Drugs Market Size, Share & Industry Analysis, By Drug Class (Alpha Blockers, 5 - Alpha Reductase Inhibitors, Others), By Application (Acute Urinary Retention, Chronic Urinary Retention), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) Others and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI102089 | Status : Ongoing

 

KEY MARKET INSIGHTS

Urinary retention is the inability to empty the urinary bladder completely and is classified among two types i.e. acute and chronic. Acute urinary retention occurs suddenly and last for a short period of time. However, it is a potentially life threatnening condition and requires immediately an emergency treatment. On other hand, chronic urinary retention can persists for a longer period of time. In most cases, patients suffering from chronic condition are able to urinate, but cannot empty their bladder completely. The urinary retention is caused by obstruction in flow of urine due to conditions like urinary tract stones, urethral stricture, prostate cancer, inflammation of urethra, etc. This disorder affects both men and women but, it tends to occur more frequently in men due to aging. According to a study published in Ethopian Journal of Health Science, urinary retention is 10 times more common in male population than in female population worldwide.


Key Market Driver -

Increasing prevalence of BPH and postoperative urinary retention

Key Market Restraint -

Availability of alternate treatment options


Globally, the urinary retention drugs market is being driven by the rising incidence of post-operative urinary retention, increasing prevalence of benign prostatic hyperplasia and availability of drugs for the treatment of the condition in the market. For instamnce, according to the American Academy of Family Physicians, approximately 250,000 surgical procedures are performed for treating patients suffering from benign prostatic hyperplasia each year in U.S. Thus, is expected to fuel the demand of urinary retention drugs for treatment of patients with BPH during the forecast period.


However, presence of alternative treatment options like catheters, urethral dilation and stents are the some of the major factors that may inhibit the growth of global urinary retention drugs market during the forecast period.


Market Segmentation:


By drug class, the global urinary retention drugs market is segmented into alpha blockers, 5-alpha reductase inhibitors and others. In terms of application, the market is categorized into acute urinary retention and chronic urinary retention. Based on distribution channel, the market is segmented into retail pharmacy, hospital pharmacy and online pharmacy.


From a geographical standpoint, the global market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.


Key Players Covered:


The major companies in the global urinary retention drugs market report includes Sanofi, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., GlaxoSmithKline plc., Eli Lilly and Company and others.


Key Insights



  • Epidemiology of Urinary Retention in Key Countries

  • Pipeline Analysis, By Key Players

  • Key Industry Developments – Partnership, Mergers and Acquisitions


Regional Analysis:


The global urinary retention drugs market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global market owing to the increasing prevalence of urinary retention, higher diagnosis rate, and high awareness among patient population towards available treatment options. For instance, according to American Academy of Family Physicians, the annual incidence rate of urinary retention in the U.S is around 4.5 to 6.8 per 1,000 men.


To gain extensive insights into the market, Request for Customization


However, increasing patient pool suffering from urinary retention and BPH in Asia Pacific along with increasing awareness among general population towards treatment options for the condition, and increasing diagnosis and treatment rates, is anticipated to fuel the demand of urinary retention drugs market in this region. On other hand, Latin America and Middle East & Africa are projected to register a moderate CAGR during the forecast period.


Segmentation


























 ATTRIBUTE


 DETAILS

By Drug Class




  • Alpha Blockers

  • 5 - Alpha Reductase Inhibitors

  • Others



By Application




  • Acute Urinary Retention

  • Chronic Urinary Retention



By Distribution Channel




  • Retail Pharmacy

  • Hospital Pharmacy

  • Online Pharmacy



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Urinary Retention Drugs Industry Developments



  • In July 2019, Eli Lilly and Company announced acquisition of Loxo Oncology, Inc., a biopharmaceutical company focused on the development and commercialization of selective medicines for patients with genomically defined cancers.


Urinary Retention Drugs Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Jubilant
Johnson
Roche
Ipsos
Ansell

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X